Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
funding
Pharma
Amicus scores $430M financing deal with asset manager Blackstone
Hot off an FDA approval for its Pompe disease combo treatment, Amicus Therapeutics has reeled in a major investor.
Fraiser Kansteiner
Oct 2, 2023 4:16pm
Epilepsy groups, lawmakers demand more funding for the condition
May 25, 2023 9:35am
Georgia Tech spinout bags cash for nucleic acid delivery R&D
Jan 24, 2023 10:36am
Teva partner bags $42M loan for long-acting injectable R&D
Nov 29, 2022 10:25am
Harvard offshoot 64x Bio nets $55M in series A funding
Jan 19, 2022 10:48am
Ori Biotech reaps $100M in series B round of fundraising
Jan 18, 2022 9:10am
